Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Meningitis × Topotecan × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Ovarian Neoplasms 91 Small Cell Lung Carcinoma 74 Neuroblastoma 44 Carcinoma, Ovarian Epithelial 42 Lung Neoplasms 39 Fallopian Tube Neoplasms 39 Neoplasms 29 Uterine Cervical Neoplasms 26 Leukemia 20 Brain Neoplasms 18 Leukemia, Myeloid, Acute 17 Recurrence 16 Sarcoma 15 Precursor Cell Lymphoblastic Leukemia-Lymphoma 15 Neoplasm Metastasis 13 Lymphoma 12 Retinoblastoma 11 Glioma 11 Central Nervous System Neoplasms 11 Carcinoma, Non-Small-Cell Lung 11 Sarcoma, Ewing 10 Unspecified Adult Solid Tumor, Protocol Specific 8 Neuroectodermal Tumors, Primitive, Peripheral 8 Myelodysplastic Syndromes 8 Medulloblastoma 8 Burkitt Lymphoma 8 Lymphoma, Follicular 7 Leukemia, Myelomonocytic, Chronic 7 Endometrial Neoplasms 7 Blast Crisis 7

Interventions

Vaccines 1 Topotecan 1 Papillomavirus Vaccines 1 Music Therapy 1 Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 1 Gemcitabine 1 Dialectical Behavior Therapy 1 Cytarabine 1 Cholecalciferol 1 Airway Extubation 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00674674 2012-05-15

PBTC-019

Baylor College of Medicine

Phase 1 Completed

Meningitis, Meningeal Carcinomatosis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡